期刊文献+

胰腺癌60例临床分析 被引量:1

Clinical analysis of 60 patients with pancreatic cancer.
暂未订购
导出
摘要 目的分析胰腺癌诊断的临床特点及影像学改变,漏诊、误诊原因。方法通过对60例经过实验室、影像学检查、手术探查和病理活检证实的胰腺癌患者,进行回顾性分析。结果60例中,术前误诊21例(30%),漏诊12例(20%),误漏诊率(50%);STB增高27例、BS增高46例、CA199增高43例、CA125增高36例;胰腺癌与难治性糖尿病、血糖持续增高、总胆红素、CA199、CA125增高有统计学差异(P<0.05);胰腺癌TNMIII期32例,81%病人有血糖、总胆红素、CA199、CA125增高,P<0.05;肿瘤转移与血糖、总胆红素、CA199、CA125有统计学意义。结论加强对胰腺癌早期症状和体征的认识,并采用B超、CT、超声胃镜、ERCP、B超引导下胰腺组织细针活检穿刺术及相关的实验室检查,能提高确诊率。 Objective To analyze the clinical characteristic and changes of ultrasonography of pancreatic cancer. Methods 60 pancreatic cancer patients were retrospectively analyzed. Results Among the 60 case 21 cases (30%) were misdiagnosed before operation and 12 cases were missing diagnosed with a missing rate of 20%. Conclusion The accuracy of diagnosis of pancreatic cancer patients be enhanced by recognition of preliminary symptom and physical characteristic of pancreatic cancer patients and integrated using the techniques of uitrasonography, CT, ultrasonic gastrocopy and uitrasonography guided biopsy.
出处 《中国热带医学》 CAS 2006年第9期1642-1643,1619,共3页 China Tropical Medicine
关键词 胰腺癌 诊断 临床分析 Pancreatic cancer Diagnosis Clinical analysis
  • 相关文献

参考文献8

二级参考文献19

  • 1[1]Ariyama J, Suyama M, Satoh K, et al. Imaging of small pan creatic ductal adenocarcinoma. Pancreas, 1998, 16(3): 396~401
  • 2[2]Fumkawa H, Okada S, Saisho H, et al. Clinicopathologic fea tures of small pancreatic adenocarcinoma A collective study.Cancer, 1996, 78(5): 986~990
  • 3[3]Ishikawa O, Ohigashi H, Imaoka S, et al. Minute carcinoma of the pancreas measuring Icm or less in diameter collective review of Japanese case reports. Hepatogastroenterology,1999, 46(25): 8~15
  • 4[4]Ritts RE, Pitt HA. CA19-9 in pancreatic cancer. Surg Oncol Clin N Am, 1998, 7(1): 93~101
  • 5[5]Nouts A, Levy P, Voitot H, et al. Diagnostic value of serumCA-19-9 antigen in chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterol Glin Biol, 1998, 22(2): 152~159
  • 6[6]Cappelli G, Paladini S, Agata A. Tumor markers in the diag nosis of pancreatic cancer. Tumori, 1999, 85(1 Suppl 1):19~21
  • 7[7]Mdaughlin R, O Hanlon D, Kerin M, et al. Are elevated levels of the tumor marker CA19-9 of any clinical signifi cance? -an evaluation. IrJ Med Sci, 1999, 168(2): 124~126
  • 8[8]Freeny PC, Lawson TL. Radiology of the pancreas. New York: Springer-Verlag, t982. 449
  • 9[9]Spinelli P, Schiavo M, Schicchi AA. Endoscopy in the diagno sis and staging of pancreatic cancer. Tumori, 1999, 85(1 Suppl 1): 14~18
  • 10[10]Okai T, Watanabe H, Yamaguchi Y, et al. EUS and K-ras analysis of pure pancreatic juice collected via a duodenoscope after secretin stimulation for diagnosis of pancreatic mass le sion: a prospective study. Gastrointest Endosc, 1999, 50(6): 797~803

共引文献45

同被引文献12

  • 1马清涌,马振华,孟勇.胰腺癌的诊断进展[J].现代肿瘤医学,2004,12(6):497-498. 被引量:9
  • 2李喆,华积德.胰腺癌早期诊断临床研究进展[J].现代实用医学,2006,18(9):609-611. 被引量:2
  • 3杨红 钱家鸣 郭涛 张惠广 邓兆斌.胰腺癌的临床特点及治疗[J].胰腺病学,2003,3:138-138.
  • 4Warshaw AL, Castillo C. Pancreatic carcinoma. New Engl J Med, 1993,326 ( 7 ) :455 - 465.
  • 5American gastroenterological association medical position statement : epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology, 1999,117 ( 6 ) : 1463 - 1484.
  • 6CalculliL, CasadeiR, DiaconoD, et al. Role of spiral computerized tomography in the staging ofpancreatic carcinoma. Radiol Med, 1998,95:344 - 348.
  • 7Athlin L, Blind PJ, Briksson S. The value of routine biochemical tests in discriminating between malignant and benign pancreatic tumor. HPB - Surg, 1991,4 ( 1 ) : 147 - 15.
  • 8Bosch VRP, Vaneijck CHJ, Mulder PGH,et al. Serum A19 - 9 determination in the management of pancreatic cancer. Hepato - Gastroenterology, 1996,43 ( 20 ) : 710 - 713.
  • 9付开国.胰腺癌45例临床分析[J].中国现代医药杂志,2007,9(8):75-77. 被引量:1
  • 10陈灏珠.实用内科学,11版[M].北京:人民卫生出版社,2001.1750.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部